Therapeutic strategy for the treatment with hypertensive renal injury

Koichi Hayashi

Research output: Contribution to journalReview articlepeer-review


Hypertension constitutes a pivotal determinant of the progression of renal disease, which would raise the risk for cardiovascular events. From the standpoint of renal micro-circulation, correction of glomerular hypertension could retard the development of renal injury, which is attainable by the reduction in renal efferent arteriolar resistance as well as systemic blood pressure. Although both ACE inhibitors and angiotensin receptor blockers are established as a tool for improving glomerular hypertension, whether calcium antagonists ameliorate this abnormality remains unclear. However, recent clinical trials including ALLHAT and INSIGHT demonstrate a beneficial action of amlodipine and nifedipine on the development of renal injury. Therefore, calcium antagonists can be used not only as a first line drug, but also as add-on therapy that could potentiate the hypotensive action of underlying medication.

Original languageEnglish
Pages (from-to)135-141
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Issue number1
Publication statusPublished - 2004 Jan

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Therapeutic strategy for the treatment with hypertensive renal injury'. Together they form a unique fingerprint.

Cite this